We use cookies to enhance your experience on our website. By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie settings at any time. Find out more The Journal of Infectious Diseases Skip to Main Content

Human Papillomavirus (HPV) Vaccines: Limited Cross-Protection against Additional HPV Types

J Infect Dis (2009) 199 (7): 919-922.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
HPV Genotypes distribution in Indian women with and without cervical carcinoma: Implication for HPV vaccination program in Odisha, Eastern India
BMC Infectious Diseases (2017) 17 (1)
Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program
The Lancet Public Health (2017) 2 (2): e96.
HLA Immunogenotype Determines Persistent Human Papillomavirus Virus Infection in HIV-Infected Patients Receiving Antiretroviral Treatment
Journal of Infectious Diseases (2016) 213 (11): 1717.
Cross-protection of the Bivalent Human Papillomavirus (HPV) Vaccine Against Variants of Genetically Related High-Risk HPV Infections
Journal of Infectious Diseases (2016) 213 (6): 939.
Natural Acquired Immunity Against Subsequent Genital Human Papillomavirus Infection: A Systematic Review and Meta-analysis
Journal of Infectious Diseases (2016) 213 (9): 1444.
Cervical HPV natural history among young Western Cape, South African women: The randomized control EVRI Trial
Journal of Infection (2016) 72 (1): 60.
Prevalence of HPV infection among 28,457 Chinese women in Yunnan Province, southwest China
Scientific Reports (2016) 6: 21039.
One stone, two birds: managing multiple common warts on hands and face by local hyperthermia
Dermatologic Therapy (2015) 28 (1): 32.
Nationwide prevalence of human papillomavirus infection and viral genotype distribution in 37 cities in China
BMC Infectious Diseases (2015) 15 (1)
Human papillomavirus prevalence in paired urine and cervical samples in women invited for cervical cancer screening
Journal of Medical Virology (2015) 87 (3): 508.
Ongoing decline in genital warts among young heterosexuals 7 years after the Australian human papillomavirus (HPV) vaccination programme
Sexually Transmitted Infections (2015) 91 (3): 214.
Large scale study of HPV genotypes in cervical cancer and different cytological cervical specimens in Thailand
Journal of Medical Virology (2014) 86 (4): 601.
Sub-acute toxicity study in female ICR mice following repetitive intramuscular injection of cervical cancer vaccine
Environmental Health and Toxicology e2014024.
Low doses of flagellin-L2 multimer vaccines protect against challenge with diverse papillomavirus genotypes
Vaccine (2014) 32 (28): 3540.
Immunogenicity of a Trivalent Human Papillomavirus L1 DNA-Encapsidated, Non-Replicable Baculovirus Nanovaccine
PLoS ONE (2014) 9 (4): e95961.
Human papillomavirus prevalence and type-distribution among women in Zhejiang Province, Southeast China: a cross-sectional study
BMC Infectious Diseases (2014) 14 (1)
Sub-acute toxicity study in female ICR mice following repetitive intramuscular injection of cervical cancer vaccines
Environmental Health and Toxicology (2014) 29: e2014024.
Development and Impact of Human Papillomavirus Vaccines
Clinical Obstetrics and Gynecology (2013) 56 (1): 10.
Prévalence des génotypes d’HPV chez les femmes en France : implications pour le dépistage et la vaccination
Gynécologie Obstétrique & Fertilité (2013) 41 (5): 305.
HPV vaccine cross-protection: Highlights on additional clinical benefit
Gynecologic Oncology (2013) 130 (3): 642.
Cervical Cancer : Is Vaccination Necessary in India?
Asian Pacific Journal of Cancer Prevention (2013) 14 (4): 2681.
Introducing human papillomavirus vaccines into the health system in South Africa
Vaccine (2012) 30: C28.
Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines
Vaccine (2012) 30 (35): 5215.
Human papillomavirus in invasive cervical cancer and cervical intraepithelial neoplasia 2 and 3 in Venezuela: A cross-sectional study
Cancer Epidemiology (2012) 36 (5): e284.
Prevalence and Genotype Distribution of Human Papillomavirus Infections in Women Attending Hospitals in Chaozhou of Guangdong Province
Asian Pacific Journal of Cancer Prevention (2012) 13 (4): 1519.
Aggregation and Competitive Exclusion: Explaining the Coexistence of Human Papillomavirus Types and the Effectiveness of Limited Vaccine Conferred Cross-Immunity
Acta Biotheoretica (2012) 60 (4): 333.
Acceptabilité de la vaccination contre les papillomavirus humains (HPV) par les pédiatres, les mères et les jeunes femmes à Hô Chi Minh Ville, Vietnam
Revue d'Épidémiologie et de Santé Publique (2012) 60 (6): 437.
Prevalence and genotype distribution of human papillomavirus infection among female sex workers in Guangxi, China: Implications for interventions
Journal of Medical Virology (2012) 84 (5): 798.
Impact of vaccine protection against multiple HPV types on the cost-effectiveness of cervical screening
Vaccine (2012) 30 (10): 1813.
Laboratory and clinical aspects of human papillomavirus testing
Critical Reviews in Clinical Laboratory Sciences (2012) 49 (4): 117.
Primäre Prävention des Zervixkarzinoms und dessen Vorstufen
Der Onkologe (2012) 18 (1): 20.
Potential Benefits of Second-Generation Human Papillomavirus Vaccines
PLoS ONE (2012) 7 (11): e48426.
Prophylaktische HPV-Impfstoffe
Der Hautarzt (2011) 62 (3): 201.
Human Papillomavirus Infection with Multiple Types: Pattern of Coinfection and Risk of Cervical Disease
Journal of Infectious Diseases (2011) 203 (7): 910.
The clinical benefit and cost-effectiveness of human papillomavirus vaccination for adult women in the Netherlands
Vaccine (2011) 29 (48): 8929.
Prevalence of genotype-specific human papillomavirus infection and cervical neoplasia in Taiwan: A community-based survey of 10,602 women
International Journal of Cancer (2011) 128 (5): 1192.
External quality assessment for molecular detection of human papillomaviruses
Journal of Clinical Virology (2010) 48 (4): 251.
Is human papillomavirus screening preferable to current policies in vaccinated and unvaccinated women? A cost-effectiveness analysis
Journal of Medical Screening (2010) 17 (4): 181.
Mothers’ preferences and willingness to pay for vaccinating daughters against human papillomavirus
Vaccine (2010) 28 (7): 1702.
A case study and comprehensive differential diagnosis and care plan for the three Ds of women's health: Primary dysmenorrhea, secondary dysmenorrhea, and dyspareunia
Journal of the American Academy of Nurse Practitioners (2010) 22 (10): 513.
Current prophylactic HPV vaccines and gynecologic premalignancies
Current Opinion in Obstetrics and Gynecology 1.
Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
The Lancet (2009) 374 (9686): 301.
Clinical update of the AS04-Adjuvanted human Papillomavirus-16/18 cervical cancer vaccine, cervarix®
Advances in Therapy (2009) 26 (11): 983.
Currently approved prophylactic HPV vaccines
Expert Review of Vaccines (2009) 8 (12): 1663.
Human papillomavirus vaccines: new tools for accelerating cervical cancer prevention in developing countries
Immunotherapy (2009) 1 (5): 795.
Advantages and Disadvantages of Current Prophylactic Vaccines Against HPV
Archives of Medical Research (2009) 40 (6): 471.
Animal models for human papillomavirus-associated cervical pathogenesis
Reviews in Medical Microbiology (2009) 20 (2): 33.
This Feature Is Available To Subscribers Only

Sign In or Create an Account

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Subscribe Now